-
1
-
-
34848868552
-
Indications for transfusions of red blood cells
-
Doyle D, Hanks GWC, Macdonald N eds, 2nd ed. Oxford: Oxford University Press
-
Turner AR: Indications for transfusions of red blood cells. In: Doyle D, Hanks GWC, Macdonald N (eds): Oxford Textbook of Palliative Medicine, 2nd ed. Oxford: Oxford University Press, 1998, pp. 771-772.
-
(1998)
Oxford Textbook of Palliative Medicine
, pp. 771-772
-
-
Turner, A.R.1
-
2
-
-
5344263788
-
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer
-
Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D: The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer. Eur J Cancer 2004;40:2293-2306
-
(2004)
Eur J Cancer
, vol.40
, pp. 2293-2306
-
-
Ludwig, H.1
Van Belle, S.2
Barrett-Lee, P.3
Birgegard, G.4
Bokemeyer, C.5
Gascon, P.6
Kosmidis, P.7
Krzakowski, M.8
Nortier, J.9
Olmi, P.10
Schneider, M.11
Schrijvers, D.12
-
3
-
-
0344844575
-
Anaemia at the end of life: Prevalence, significance, and causes in patients receiving palliative care
-
Dunn A, Carter J, Carter H: Anaemia at the end of life: Prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manage 2003;26:1132-1139.
-
(2003)
J Pain Symptom Manage
, vol.26
, pp. 1132-1139
-
-
Dunn, A.1
Carter, J.2
Carter, H.3
-
4
-
-
0035367087
-
Effects of erythropoietin alfa on haematological parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomised, double-blind, placebo-controlled trial
-
Littlewood TJ, Bajetta E, Nortier JWR, Vercammen E, Rapoport B: Effects of erythropoietin alfa on haematological parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomised, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-2874.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2865-2874
-
-
Littlewood, T.J.1
Bajetta, E.2
Nortier, J.W.R.3
Vercammen, E.4
Rapoport, B.5
-
5
-
-
0035366382
-
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
-
Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875-2882.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2875-2882
-
-
Gabrilove, J.L.1
Cleeland, C.S.2
Livingston, R.B.3
Sarokhan, B.4
Winer, E.5
Einhorn, L.H.6
-
6
-
-
0031044609
-
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
-
Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 1997;15:1218-1234.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1218-1234
-
-
Glaspy, J.1
Bukowski, R.2
Steinberg, D.3
Taylor, C.4
Tchekmedyian, S.5
Vadhan-Raj, S.6
-
7
-
-
0031785826
-
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
-
Demetri G, Kris M, Wade J, Degos L, Cella D: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. J Clin Oncol 1998;16:3412-3425
-
(1998)
J Clin Oncol
, vol.16
, pp. 3412-3425
-
-
Demetri, G.1
Kris, M.2
Wade, J.3
Degos, L.4
Cella, D.5
-
8
-
-
0035503198
-
Canadian Eprex Oncology Study Group: Erythropoietin alfa therapy increases haemoglobin levels and improves quality of life in patients with cancer-related anaemia who are not receiving chemotherapy and patients with anaemia who are receiving chemotherapy
-
Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F; Canadian Eprex Oncology Study Group: Erythropoietin alfa therapy increases haemoglobin levels and improves quality of life in patients with cancer-related anaemia who are not receiving chemotherapy and patients with anaemia who are receiving chemotherapy. J Clin Oncol 2001;19:4126-4134.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4126-4134
-
-
Quirt, I.1
Robeson, C.2
Lau, C.Y.3
Kovacs, M.4
Burdette-Radoux, S.5
Dolan, S.6
Tang, S.C.7
McKenzie, M.8
Couture, F.9
-
9
-
-
23344434516
-
Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anaemia not receiving anticancer treatment
-
Mystakidou K, Kalaidopoulou O, Katsouda E, Parpa E, Kouskouni E, Chondros C, Tsiatas ML, Vlahos L: Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anaemia not receiving anticancer treatment. Anticancer Res 2005;25:3495-3500.
-
(2005)
Anticancer Res
, vol.25
, pp. 3495-3500
-
-
Mystakidou, K.1
Kalaidopoulou, O.2
Katsouda, E.3
Parpa, E.4
Kouskouni, E.5
Chondros, C.6
Tsiatas, M.L.7
Vlahos, L.8
-
10
-
-
0028849076
-
Blood transfusion and its benefits in palliative care
-
Gleeson C, Spencer D: Blood transfusion and its benefits in palliative care. Palliat Med 1995;9:307-313.
-
(1995)
Palliat Med
, vol.9
, pp. 307-313
-
-
Gleeson, C.1
Spencer, D.2
-
11
-
-
2642563845
-
Use of red blood cell transfusions in palliative care services: Is it still up to date or is cancer-related anaemia controlled better with erythropoietic agents? [letter]
-
Tanneberger S, Melilli G, Strocchi E, Frenquelli C, Pannuti QF: Use of red blood cell transfusions in palliative care services: Is it still up to date or is cancer-related anaemia controlled better with erythropoietic agents? [letter]. Ann Oncol 2004;15:839-40.
-
(2004)
Ann Oncol
, vol.15
, pp. 839-840
-
-
Tanneberger, S.1
Melilli, G.2
Strocchi, E.3
Frenquelli, C.4
Pannuti, Q.F.5
-
12
-
-
0029994038
-
Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit
-
Monti M, Castellani L, Berlusconi A, Cunietti E: Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit. Pain Symptom Manage 1996;12:18-22.
-
(1996)
Pain Symptom Manage
, vol.12
, pp. 18-22
-
-
Monti, M.1
Castellani, L.2
Berlusconi, A.3
Cunietti, E.4
-
13
-
-
0034598130
-
Using the modified Barthel index to estimate survival in cancer patients in hospice: Observational study
-
Bennett MI, Ryall N: Using the modified Barthel index to estimate survival in cancer patients in hospice: Observational study. Br Med J 2000;321:1381-1382.
-
(2000)
Br Med J
, vol.321
, pp. 1381-1382
-
-
Bennett, M.I.1
Ryall, N.2
-
14
-
-
0037102975
-
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
-
Crawford J, Cella D, Cleeland CS, Cremieux P, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA: Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002;95:888-895.
-
(2002)
Cancer
, vol.95
, pp. 888-895
-
-
Crawford, J.1
Cella, D.2
Cleeland, C.S.3
Cremieux, P.4
Demetri, G.D.5
Sarokhan, B.J.6
Slavin, M.B.7
Glaspy, J.A.8
-
15
-
-
13544268215
-
Symptom clusters: The new frontier in symptom management research
-
Miaskowski C, Dodd M, Lee K: Symptom clusters: The new frontier in symptom management research. J Natl Cancer Inst Monogr 2004;32:17-21.
-
(2004)
J Natl Cancer Inst Monogr
, vol.32
, pp. 17-21
-
-
Miaskowski, C.1
Dodd, M.2
Lee, K.3
|